Mentioned On
Episode Mentions
Pharma and BioTech Daily · May 13, 2026
Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily
“Announced $15B partnership with Hengrui Pharma to advance 13 early-stage programs leveraging China's R&D capabilities”
FDA Leadership Transition and Regulatory StrategyPrecision Oncology and Targeted Breast Cancer TherapiesBiosimilar Competition and Market Erosion
View AnalysisThe BioHub - by Avetix · May 12, 2026
Episode 172 - Jonathan Sadeh - EVP, Head of R&D and CMO of Bausch Health
“Previous employer where Dr. Sadeh held senior R&D leadership role before joining Bausch Health”
Career progression in large pharmaceutical organizationsCross-functional collaboration in drug developmentTherapeutic area diversification strategy
View AnalysisMotley Fool Money · Feb 22, 2026
How to Spot Winning Innovation
“Mentioned as company where Lorraine Marchand held previous leadership role in healthcare and life sciences”
Innovation Framework and StrategyOrganizational Culture and Psychological SafetyRisk Management and Strategic vs. Reckless Risk
View AnalysisThe a16z Show · Feb 16, 2026
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
“Competitor mentioned in cell therapy development alongside other major pharma companies”
Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology
View AnalysisDecoded | Unlock The Secrets of Human Behavior, Emotion and Motivation · Jan 22, 2026
When Human Biology Evolves Slower Than the World with James Schmachtenberger
“Former employer of Sean Raymer, senior VP of drug discovery who joined Qualia's science team early on”
Complex Systems Science Applied to Human BiologyGut-Brain Axis and Neurotransmitter ProductionReductionist vs. Systems-Based Medical Models
View Analysis